Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy
Meng-Chao Luo,1,2,* Jia-Yi Wu,1,3,* Jun-Yi Wu,1,3 Zhong-Tai Lin,1,2 Yi-Nan Li,3 Zhen-Xin Zeng,3 Shao-Ming Wei,1,2 Mao-Lin Yan1,3 1Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, 350001, People’s Republic of China; 2Department of General Surgery...
Autori principali: | Luo MC, Wu JY, Lin ZT, Li YN, Zeng ZX, Wei SM, Yan ML |
---|---|
Natura: | Articolo |
Lingua: | English |
Pubblicazione: |
Dove Medical Press
2023-10-01
|
Serie: | Journal of Hepatocellular Carcinoma |
Soggetti: | |
Accesso online: | https://www.dovepress.com/early-tumor-marker-response-predicts-treatment-outcomes-in-patients-wi-peer-reviewed-fulltext-article-JHC |
Documenti analoghi
Documenti analoghi
-
Development and Validation of a Prognostic Nomogram for Patients with AFP and DCP Double-Negative Hepatocellular Carcinoma After Local Ablation
di: Qiao W, et al.
Pubblicazione: (2024-02-01) -
Clinical value of alpha-fetoprotein: alpha-fetoprotein-L3 isoform ratio and des-γ-carboxyprothrombin in early diagnosis of HBV-related hepatocellular carcinoma
di: Duan Jianping, Du Lei, Song Ting, Liu Zhensheng
Pubblicazione: (2023-08-01) -
Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study
di: Liu DY, et al.
Pubblicazione: (2024-11-01) -
Validation of a novel model for the early detection of hepatocellular carcinoma
di: Philip M. Hemken, et al.
Pubblicazione: (2019-01-01) -
Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment
di: Daniel R A Cox, et al.
Pubblicazione: (2023-04-01)